Inhibitor of DNA binding 2 (ID2) regulates key transcriptional programs in multiple myeloma

Authors :: Mehmet Kemal Samur
Yan Xu
Kenneth C. Anderson
Enrico Milan
Nicola Amodio
Eugenio Morelli
Nikhil C. Munshi
Simone Cenci
Mariateresa Fulciniti
Christopher J. Ott
Kenneth Wen
Matthew A. Lawlor
Fabio Ciceri
Raphael Szalat
Tommaso Perini
Source :: Clinical Lymphoma Myeloma and Leukemia. 19:e98-e99
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Cancer Research
chemistry.chemical_compound
Oncology
chemistry
business.industry
medicine
Key (cryptography)
Hematology
Computational biology
medicine.disease
business
Multiple myeloma
DNA

Full Text Access

Tools